PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.88%
Negative net income growth while META stands at 33.04%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
2.24%
Less D&A growth vs. META's 6.19%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-395.16%
Negative yoy deferred tax while META stands at 62.86%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-6.13%
Negative yoy SBC while META is 8.57%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
56.25%
Slight usage while META is negative at -98.92%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-307.62%
Both yoy AR lines negative, with META at -131.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
2454.17%
Some inventory rise while META is negative at -100.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
680.00%
A yoy AP increase while META is negative at -203.45%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
42.63%
Some yoy usage while META is negative at -33.33%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
210.00%
Well above META's 40.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-0.66%
Both yoy CFO lines are negative, with META at -9.73%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-39.85%
Both yoy lines negative, with META at -36.03%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-12.70%
Both yoy lines negative, with META at -1800.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
21.11%
Less growth in investment purchases vs. META's 66.63%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-17.66%
We reduce yoy sales while META is 140.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-193.66%
Both yoy lines negative, with META at -87.50%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-32.26%
We reduce yoy invests while META stands at 94.59%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-183.33%
Both yoy lines negative, with META at -15.22%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Buyback growth of 200.00% while META is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.